Cardinal Capital Management Inc. Buys 50,545 Shares of Nutrien Ltd. (NYSE:NTR)

Cardinal Capital Management Inc. increased its stake in Nutrien Ltd. (NYSE:NTR - Free Report) by 9.3% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 595,187 shares of the company's stock after purchasing an additional 50,545 shares during the quarter. Cardinal Capital Management Inc. owned 0.12% of Nutrien worth $29,552,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in NTR. Norges Bank purchased a new stake in Nutrien in the fourth quarter worth approximately $241,958,000. Arrowstreet Capital Limited Partnership boosted its holdings in Nutrien by 159.5% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 5,435,627 shares of the company's stock worth $242,976,000 after purchasing an additional 3,341,169 shares during the last quarter. Barclays PLC boosted its holdings in Nutrien by 192.7% in the fourth quarter. Barclays PLC now owns 411,056 shares of the company's stock worth $18,395,000 after purchasing an additional 854,543 shares during the last quarter. Deutsche Bank AG boosted its holdings in Nutrien by 11.3% in the fourth quarter. Deutsche Bank AG now owns 7,105,057 shares of the company's stock worth $317,951,000 after purchasing an additional 721,935 shares during the last quarter. Finally, Geode Capital Management LLC boosted its holdings in Nutrien by 30.3% in the fourth quarter. Geode Capital Management LLC now owns 3,022,551 shares of the company's stock worth $137,202,000 after purchasing an additional 702,948 shares during the last quarter. Hedge funds and other institutional investors own 63.10% of the company's stock.

Nutrien Price Performance

Shares of NTR stock traded up $2.43 on Friday, hitting $62.87. 4,158,076 shares of the stock traded hands, compared to its average volume of 2,169,557. The firm has a market cap of $30.66 billion, a price-to-earnings ratio of 45.89, a PEG ratio of 1.19 and a beta of 0.81. Nutrien Ltd. has a 52 week low of $43.70 and a 52 week high of $62.89. The firm has a 50 day simple moving average of $56.03 and a two-hundred day simple moving average of $51.84. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.27 and a quick ratio of 0.82.

Nutrien (NYSE:NTR - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.11 EPS for the quarter, missing the consensus estimate of $0.35 by ($0.24). The firm had revenue of $4.67 billion for the quarter, compared to the consensus estimate of $5.16 billion. Nutrien had a net margin of 2.62% and a return on equity of 6.81%. The firm's revenue for the quarter was down 5.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.46 earnings per share. As a group, equities research analysts predict that Nutrien Ltd. will post 3.72 earnings per share for the current fiscal year.

Nutrien Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 18th. Shareholders of record on Monday, June 30th will be issued a $0.545 dividend. The ex-dividend date is Monday, June 30th. This represents a $2.18 dividend on an annualized basis and a yield of 3.47%. Nutrien's dividend payout ratio is currently 203.74%.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on NTR. BNP Paribas upgraded shares of Nutrien to a "strong-buy" rating in a report on Wednesday, April 9th. Mizuho increased their price target on shares of Nutrien from $52.00 to $55.00 and gave the stock a "neutral" rating in a research report on Thursday, February 20th. Scotiabank downgraded shares of Nutrien from an "outperform" rating to a "sector perform" rating and set a $62.00 price target on the stock. in a research report on Thursday, May 22nd. Barclays increased their price target on shares of Nutrien from $59.00 to $61.00 and gave the stock an "equal weight" rating in a research report on Wednesday, May 14th. Finally, Oppenheimer increased their price target on shares of Nutrien from $58.00 to $63.00 and gave the stock an "outperform" rating in a research report on Tuesday, May 13th. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating, eight have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Nutrien has a consensus rating of "Hold" and an average target price of $61.44.

Nutrien Company Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.